{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T13:25:33Z","timestamp":1784381133249,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"The Dunk Hypertension Fund"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ecl.2019.08.015","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T18:13:29Z","timestamp":1571854409000},"page":"657-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cardiovascular Risks and Organ Damage in Secondary Hypertension"],"prefix":"10.1016","volume":"48","author":[{"given":"Oscar H.","family":"Cingolani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2019.08.015_bib1","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","article-title":"Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Forouzanfar","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2019.08.015_bib2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","article-title":"Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data","volume":"384","year":"2014","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.015_bib3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jash.2016.02.015","article-title":"Evidence for a critical role of the sympathetic nervous system in hypertension","volume":"10","author":"Grassi","year":"2016","journal-title":"J\u00a0Am Soc Hypertens"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.015_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00424-011-1020-8","article-title":"In\u00a0vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy","volume":"462","author":"Cingolani","year":"2011","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.ecl.2019.08.015_bib5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0889-8529(18)30425-0","article-title":"Primary aldosteronism. Diagnostic evaluation","volume":"17","author":"Young","year":"1988","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.015_bib6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/HYPERTENSIONAHA.119.12935","article-title":"Primary aldosteronism","volume":"74","author":"Funder","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2019.08.015_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJM199002083220601","article-title":"Association of hypokalemia, aldosteronism and renal cysts","volume":"322","author":"Torres","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ecl.2019.08.015_bib8","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2019.08.015_bib9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.27.5.1039","article-title":"Changes in left ventricular anatomy and function in patients with primary aldosteronism","volume":"27","author":"Rossi","year":"1996","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.ecl.2019.08.015_bib10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.015_bib11","first-page":"41","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticoni","year":"2018","journal-title":"LancetDiabetes Endocrinol"},{"key":"10.1016\/j.ecl.2019.08.015_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1523-1755.2005.00406.x","article-title":"Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis","volume":"68","author":"Kalra","year":"2005","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.015_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archinte.165.2.207","article-title":"Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study","volume":"165","author":"Edwards","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ecl.2019.08.015_bib14","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMra032393","article-title":"Fibromuscular dysplasia","volume":"350","author":"Slovut","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.015_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jacc.2016.04.044","article-title":"Dissection and aneurysm in patients with fibromuscular dysplasia: findings from the U.S. registry for FMD","volume":"68","author":"Kadian-Dodov","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ecl.2019.08.015_bib16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.111.179788","article-title":"Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension","volume":"58","author":"Pedrosa","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2019.08.015_bib17","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/00004872-200112000-00022","article-title":"High prevalence of unrecognized sleep apnoea in drug-resistant hypertension","volume":"19","author":"Logan","year":"2001","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2019.08.015_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/sleep\/26.1.15","article-title":"Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea","volume":"26","author":"Fletcher","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.ecl.2019.08.015_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.autneu.2005.06.003","article-title":"Effects of intermittent hypoxia on sympathetic activity and blood pressure in humans","volume":"121","author":"Leuenberger","year":"2005","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.ecl.2019.08.015_bib20","first-page":"15","article-title":"Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive sleep apnea-hypopnea syndrome and its mechanisms","volume":"127","author":"Alonso-Fernandez","year":"2005","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ecl.2019.08.015_bib21","first-page":"340","article-title":"Sleep apnea, cardiac arrhythmias, and sudden death","volume":"38","author":"Ludka","year":"2011","journal-title":"Tex Heart Inst J"},{"issue":"15","key":"10.1016\/j.ecl.2019.08.015_bib22","doi-asserted-by":"crossref","first-page":"e008808","DOI":"10.1161\/JAHA.118.008808","article-title":"Impact of obstructive sleep apnea on platelet function profiles in patients with acute coronary syndrome taking dual antiplatelet therapy","volume":"7","author":"Gong","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.015_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020445","article-title":"Obstructive sleep apnea activates HIF-1 in a hypoxia dose-dependent manner in HCT116 colorectal carcinoma cells","volume":"20","author":"Martinez","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ecl.2019.08.015_bib24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.HYP.0000116223.97436.e5","article-title":"Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy","volume":"43","author":"Goodfriend","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ecl.2019.08.015_bib25","doi-asserted-by":"crossref","first-page":"45241","DOI":"10.1038\/srep45241","article-title":"Association of aldosterone excess and apnea-hypopnea index in patients with resistant hypertension","volume":"7","author":"Ke","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.015_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3109\/10641963.2015.1131290","article-title":"Effect of spironolactone on patients with resistant hypertension and obstructive sleep apnea","volume":"38","author":"Yang","year":"2016","journal-title":"Clin Exp Hypertens"},{"issue":"4","key":"10.1016\/j.ecl.2019.08.015_bib27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0895-7061(02)03267-3","article-title":"Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea","volume":"16","author":"M\u00f8ller","year":"2003","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.015_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amjhyper.2006.05.021","article-title":"Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease","volume":"20","author":"Gj\u00f8rup","year":"2007","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.015_bib29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1113\/jphysiol.2014.282871","article-title":"Cushing's syndrome: from physiological principles to diagnosis and clinical care","volume":"593","author":"Raff","year":"2015","journal-title":"J\u00a0Physiol"},{"issue":"46","key":"10.1016\/j.ecl.2019.08.015_bib30","doi-asserted-by":"crossref","first-page":"e2011","DOI":"10.1097\/MD.0000000000002011","article-title":"Dilated cardiomyopathy revealing cushing disease: a case report and literature review","volume":"94","author":"Marchand","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2019.08.015_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000314319","article-title":"Pathophysiology of diabetes mellitus in Cushing\u2019s syndrome","volume":"92","author":"Pivonello","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ecl.2019.08.015_bib32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2002.tb04419.x","article-title":"Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases","volume":"970","author":"Torpy","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ecl.2019.08.015_bib33","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1097\/01.hjh.0000379122.23823.8e","article-title":"Early target organ damage in patients with pheochromocytoma, obstructive sleep apnea and essential hypertension","volume":"28","author":"Zielen","year":"2010","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ecl.2019.08.015_bib34","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2018-02644","article-title":"Blood pressure profile, catecholamine phenotype and target organ damage in pheochromocytoma\/paraganglioma","author":"Petr\u00e1k","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1 Pt 1","key":"10.1016\/j.ecl.2019.08.015_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0895-7061(99)00139-9","article-title":"Changes in clinical features and long-term prognosis in patients with pheochromocytoma","volume":"13","author":"Noshiro","year":"2000","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.015_bib36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.ackd.2014.11.002","article-title":"Catecholamine excess: pseudopheochromocytoma and beyond","volume":"22","author":"Garcha","year":"2015","journal-title":"Adv ChronicKidney Dis"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.015_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.14740\/cr471w","article-title":"A\u00a0sudden change of heart: a case of rapidly reversed stress cardiomyopathy in a critically ill patient","volume":"7","author":"Brener","year":"2016","journal-title":"Cardiol Res"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.015_bib38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.14503\/THIJ-17-6407","article-title":"Pheochromocytoma-induced Takotsubo cardiomyopathy","volume":"46","author":"Afana","year":"2019","journal-title":"Tex Heart Inst J"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.015_bib39","article-title":"Extra-adrenal pheochromocytoma presenting as inverse takotsubo-pattern cardiomyopathy treated with surgical resection","volume":"11","author":"Tafreshi","year":"2018","journal-title":"BMJCase Rep"},{"issue":"12","key":"10.1016\/j.ecl.2019.08.015_bib40","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jacep.2017.01.014","article-title":"Plasma catecholamine levels on the morning of surgery predict post-operative atrial fibrillation","volume":"3","author":"Anderson","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"issue":"8","key":"10.1016\/j.ecl.2019.08.015_bib41","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood-2015-07-660746","article-title":"Sympathetic stimulation facilitates thrombopoiesis by promoting megakaryocyte adhesion, migration, and proplatelet formation","volume":"127","author":"Chen","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ecl.2019.08.015_bib42","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1161\/CIRCULATIONAHA.113.007360","article-title":"A\u00a0Nervous Heart","volume":"129","author":"Cingolani","year":"2014","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ecl.2019.08.015_bib43","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2019.08.015_bib44","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/er.2003-0033","article-title":"Thyroid hormone action in the heart","volume":"26","author":"Kahaly","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2019.08.015_bib45","first-page":"4701","article-title":"Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients","volume":"85","author":"Biondi","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2019.08.015_bib46","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1073\/pnas.89.12.5251","article-title":"Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism","volume":"89","author":"Ladenson","year":"1992","journal-title":"Proc Natl Acad Sci US A"},{"key":"10.1016\/j.ecl.2019.08.015_bib47","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system","volume":"344","author":"Klein","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ecl.2019.08.015_bib48","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4330\/wjc.v7.i11.765","article-title":"Coarctation of the aorta: management from infancy to adulthood","volume":"7","author":"Torok","year":"2015","journal-title":"World J Cardiol"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.015_bib49","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/hrt.32.5.633","article-title":"Natural history of coarctation of the aorta","volume":"32","author":"Campbell","year":"1970","journal-title":"Br Heart J"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.015_bib50","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1590\/1806-9282.65.2.240","article-title":"The importance of the early diagnosis of aorta coarctation","volume":"65","author":"Cangussu","year":"2019","journal-title":"Rev Assoc Med Bras(1992)"},{"issue":"4","key":"10.1016\/j.ecl.2019.08.015_bib51","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4070\/kcj.2018.0433","article-title":"Management of coarctation of the aorta in adult patients: state of the art","volume":"49","author":"Alkashkari","year":"2019","journal-title":"Korean Circ J"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.015_bib52","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2214\/ajr.127.2.227","article-title":"Takayasu's arteritis and congenital coarctation of the descending thoracic and abdominal aorta: a critical review","volume":"127","author":"Lande","year":"1976","journal-title":"AJR Am J Roentgenol"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852919300696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852919300696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:45:06Z","timestamp":1760175906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852919300696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0889852919300696"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2019.08.015","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Risks and Organ Damage in Secondary Hypertension","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2019.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}